Delivery Order SPE2DE21D0005-SPE2D622F17Z8
Award Date 12/3/21
Potential Completion Date 12/9/21
Potential Value $8.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $5,790.00 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract is for PURAPLY AM XT 4.91X4.91, an advanced wound care dressing used for surgical and wound treatment applications. The award utilized fixed-price pricing with economic price adjustment provisions and was not designated as a...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, has been awarded a delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for PURAPLY AM XT 4.91X4.91 wound care dressings. The fixed-price delivery order, valued at $11,580.00, was awarded on August 15, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, allowing the company to compete as a standard commercial vendor. The place of...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency's Medical Supply Chain division on September 23, 2025. The contract, which operates under a fixed-price arrangement with economic price adjustment provisions, is for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The delivery order is scheduled for completion by September 26, 2025, and was awarded...
- The U.S. Department of Defense's Medical Supply Chain (Defense Logistics Agency Troop Support Medical) has awarded Organogenesis Inc. a $8,500.00 fixed-price delivery order contract (SPE2DE21D0005|SPE2D624F9CS2) for the supply of PURAPLY AM XT 4.91x4.91 medical products. This delivery order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials. Organogenesis is...
- This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, which does not have a set-aside designation, is a Delivery Order for PURAPLY AM XT 4.91X4.91 medical supplies. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, particularly the Department of...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency (DLA) on November 13, 2025, for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The contract is a fixed-price delivery with economic price adjustment provisions and carries an ultimate completion date of November 18, 2025. This award represents a single delivery order executed without set-aside...
- The Defense Logistics Agency Troop Support Medical awarded a $7,620 fixed-price delivery order to Organogenesis Inc. for 4556008515 PURAPLY AM (2X4) 8 SQ CM. Organogenesis Inc. will deliver the medical materials from its Canton, MA division under the one-week contract running from January 21 to 27, 2022. No subcontractors or set aside designations were specified. The Defense Logistics Agency supports the armed forces by procuring, managing and supplying critical equipment, materials, services...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a $17.82K delivery order on September 9, 2025, for PURAPLY SX 6CM x 9CM wound care dressings. This fixed-price contract with economic price adjustment carries an ultimate completion date of September 12, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The award was made on a competitive basis with no set-aside designation, reflecting...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 by the Defense Logistics Agency's Medical Supply Chain division on October 28, 2025, with an ultimate completion date of October 31, 2025. The award covers APLIGRAF, an advanced skin substitute product used for wound care and tissue regeneration. This delivery order was issued under a fixed-price contract with economic price adjustment terms and did not...